Newer drugs helping MS patients stay in work

The study is the first to look at employment outcomes with disease-modifying therapies

A growing number of people living with MS are staying in work, according to research commissioned by MS Research Australia and prepared by the Menzies Institute for Medical Research at the University of Tasmania.

The researchers analysed five years of data from nearly 900 working MS patients included in the Australian MS Longitudinal Study to look at the effects of disease-modifying therapies on their work lives.

Those using the most effective drugs were 2-3 times more likely to report improvements in the amount of work they were able to perform than those using classic injectable therapies. 

“This can be used to support the case that these drugs have an important, practical and positive impact on work life for people with MS," said co-author PhD student Jing Chen.

"These findings are very exciting as it is the first time employment outcomes have been